266 related articles for article (PubMed ID: 26328498)
21. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
22. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Redrobe JP; Bourin M
Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
[TBL] [Abstract][Full Text] [Related]
23. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
Stahl SM; Grady MM; Moret C; Briley M
CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
[TBL] [Abstract][Full Text] [Related]
24. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
[TBL] [Abstract][Full Text] [Related]
25. [Differential features of SSRIs].
Cervera S
Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
[TBL] [Abstract][Full Text] [Related]
26. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Jones CK; Eastwood BJ; Need AB; Shannon HE
Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
[TBL] [Abstract][Full Text] [Related]
27. [Selective serotonin reuptake inhibitors--current knowledge].
Dudek D; Zieba A; Siwek M; Wróbel A
Psychiatr Pol; 2004; 38(3):507-24. PubMed ID: 15199659
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
Maurel S; De Vry J; Schreiber R
Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
[TBL] [Abstract][Full Text] [Related]
29. Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.
Saitoh A; Yamaguchi K; Tatsumi Y; Murasawa H; Nakatani A; Hirose N; Yamada M; Yamada M; Kamei J
Psychopharmacology (Berl); 2007 May; 191(4):857-65. PubMed ID: 17318509
[TBL] [Abstract][Full Text] [Related]
30. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
Preskorn SH
Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
[TBL] [Abstract][Full Text] [Related]
31. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
[TBL] [Abstract][Full Text] [Related]
32. The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval.
Di Mascio M; Esposito E
Neuroscience; 1997 Aug; 79(4):957-61. PubMed ID: 9219958
[TBL] [Abstract][Full Text] [Related]
33. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
[TBL] [Abstract][Full Text] [Related]
34. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
Azizi M; Khani S; Kamali M; Elyasi F
Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
[TBL] [Abstract][Full Text] [Related]
35. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
[TBL] [Abstract][Full Text] [Related]
36. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
Nagayasu K; Kitaichi M; Nishitani N; Asaoka N; Shirakawa H; Nakagawa T; Kaneko S
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436
[TBL] [Abstract][Full Text] [Related]
37. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
38. Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
Stahl SM
J Clin Psychiatry; 1998 Dec; 59(12):642-3. PubMed ID: 9921697
[No Abstract] [Full Text] [Related]
39. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
Felton TM; Kang TB; Hjorth S; Auerbach SB
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
[TBL] [Abstract][Full Text] [Related]
40. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
